Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study
Spebrutinib (CC-292) 影响类风湿关节炎患者的 B 细胞活化、趋化性和破骨细胞标志物：机制研究结果
期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-019-00182-7
Peter H Schafer, Alan J Kivitz, Jianglin Ma, Shimon Korish, Donna Sutherland, Li Li, Ada Azaryan, Jolanta Kosek, Mary Adams, Lori Capone, Eun Mi Hur, Douglas R Hough, Garth E Ringheim
